Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1454 | Experimental: PIVOT with MI Wiki | 1.00 |
drug3874 | TD-0903 Wiki | 0.71 |
drug2916 | Placebo Wiki | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
D055370 | Lung Injury NIH | 0.19 |
D055371 | Acute Lung Injury NIH | 0.08 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.07 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The overall goal of this project is to determine whether a novel and innovative provider communication strategy is effective in improving vaccine acceptance among vaccine-hesitant parents (VHPs) and visit experience among VHPs and their health care providers.
Description: Immunization status will be obtained from either state's immunization registry or directly from the participating practices.
Measure: Child's Immunization Status Time: Child's immunization status at 19 months of ageDescription: To assess parent visit experience, we will administer surveys to all vaccine hesitant parents within 24-48 hours after the completion of their health supervision visit. (Update: Due to COVID-19 restrictions, we have extended the time frame to within 1 week after their health supervision visit)
Measure: Parent Visit Experience Survey Time: Within 1 week after a health supervision visitDescription: To assess provider perception of the vaccine discussion with parents, we will administer surveys to all study providers at baseline and at study completion to establish changes in provider perception.
Measure: Change in Provider Perception of Vaccine Discussion - Pre- and Post-Surveys Time: At Baseline (year 1) and Post-Intervention (years 4 and 5)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports